期刊论文详细信息
BMC Psychiatry
Blended vs. face-to-face cognitive behavioural treatment for major depression in specialized mental health care: study protocol of a randomized controlled cost-effectiveness trial
Heleen Riper3  Pim Cuijpers3  Joran Lokkerbol2  Filip Smit4  Patricia van Oppen5  Jeroen Ruwaard1  Jenneke E Wiersma5  Lisa C Kooistra1 
[1] EMGO institute for Health Care and Research, VU University Medical Centre, Van der Boechorststraat 7, Amsterdam, 1081, BT, the Netherlands;Trimbos Institute, Utrecht 3500, AS, the Netherlands;Leuphana University, Innovation Incubator, Division Health Trainings online, Rotenbleicher Weg 67, Lüneburg 21335, Germany;Department of Epidemiology and Biostatistics, VU University Medical Centre, Utrecht 3500, AS, the Netherlands;Department of Psychiatry, GGZ inGeest and VU University Medical Centre, Amsterdam 1007, MB, the Netherlands
关键词: Randomized controlled trial;    Pilot;    Specialized mental health care;    Outpatients;    Cost-effectiveness;    Blended treatment;    Cognitive behavioural therapy;    Internet-based treatment;    Depression;   
Others  :  1123308
DOI  :  10.1186/s12888-014-0290-z
 received in 2014-09-29, accepted in 2014-10-08,  发布年份 2014
PDF
【 摘 要 】

Background

Depression is a prevalent disorder, associated with a high disease burden and substantial societal, economic and personal costs. Cognitive behavioural treatment has been shown to provide adequate treatment for depression. By offering this treatment in a blended format, in which online and face-to-face treatment are combined, it might be possible to reduce the number of costly face-to-face sessions required to deliver the treatment protocol. This could improve the cost-effectiveness of treatment, while maintaining clinical effects. This protocol describes the design of a pilot study for the evaluation of the feasibility, acceptability and cost-effectiveness of blended cognitive behavioural therapy for patients with major depressive disorder in specialized outpatient mental health care.

Methods/design

In a randomized controlled trial design, adult patients with major depressive disorder are allocated to either blended cognitive behavioural treatment or traditional face-to-face cognitive behavioural treatment (treatment as usual). We aim to recruit one hundred and fifty patients. Blended treatment will consist of ten face-to-face and nine online sessions provided alternately on a weekly basis. Traditional cognitive behavioural treatment will consist of twenty weekly sessions. Costs and effects are measured at baseline and after 10, 20 and 30 weeks. Evaluations are directed at cost-effectiveness (with depression severity and diagnostic status as outcomes), and cost-utility (with costs per quality adjusted life year, QALY, as outcome). Costs will encompass health care uptake costs and productivity losses due to absence from work and lower levels of efficiency while at work. Other measures of interest are mastery, working alliance, treatment preference at baseline, depressive cognitions, treatment satisfaction and system usability.

Discussion

The results of this pilot study will provide an initial insight into the feasibility and acceptability of blended cognitive behavioural treatment in terms of clinical and economic outcomes (proof of concept) in routine specialized mental health care settings, and an indication as to whether a well-powered clinical trial of blended cognitive behavioural treatment for depression in routine practice would be advisable. This will be determined based on the perspective of various stakeholders including patients, mental health service providers and health insurers. Strengths and limitations of the study are discussed.

Trial registration

Netherlands Trial Register NTR4650 webcite. Registered 18 June 2014.

【 授权许可】

   
2014 Kooistra et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150216030404434.pdf 472KB PDF download
Figure 1. 34KB Image download
【 图 表 】

Figure 1.

【 参考文献 】
  • [1]Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:617-627.
  • [2]Lépine J-P, Briley M: The increasing burden of depression. Neuropsychiatr Dis Treat 2011, 7(Suppl 1):3-7.
  • [3]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
  • [4]Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A: Costs of nine common mental disorders: implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006, 9:193-200.
  • [5]Cuijpers P, Smit F, Oostenbrink J, de Graaf R, Ten Have M, Beekman A: Economic costs of minor depression: a population-based study. Acta Psychiatr Scand 2007, 115:229-236.
  • [6]Watkins KE, Burnam MA, Orlando M, Escarce JJ, Huskamp HA, Goldman HH: The health value and cost of care for major depression. Value Health 2009, 12:65-72.
  • [7]Een Analyse van de Verwachte Kosten en Baten van eHealth, Blended Behandelen en Begeleiden - An Analysis of the Expected Costs and Benefits of eHealth, Blended Treatment and Guidance. GGZ Nederland, Amersfoort; 2013.
  • [8]Kohn R, Saxena S, Levav I, Saraceno B: The treatment gap in mental health care. Bull World Health Organ 2004, 82:858-866.
  • [9]Richards D, Richardson T: Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev 2012, 32:329-342.
  • [10]Andersson G, Cuijpers P: Pros and cons of online cognitive-behavioural therapy. Br J Psychiatry 2008, 193:270-271.
  • [11]Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N: Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One 2010, 5:e13196.
  • [12]Johansson R, Andersson G: Internet-based psychological treatments for depression. Expert Rev Neurother 2012, 12:861-870.
  • [13]Andersson G, Cuijpers P: Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cogn Behav Ther 2009, 38:196-205.
  • [14]Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E: Internet-based vs. face-to-face cognitive behaviour therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry 2014, 13:288-295.
  • [15]Warmerdam L, Smit F, van Straten A, Riper H, Cuijpers P: Cost-utility and cost-effectiveness of internet-based treatment for adults with depressive symptoms: randomized trial. J Med Internet Res 2010, 12:e53.
  • [16]Lokkerbol J, Adema D, Cuijpers P, Reynolds CF, Schulz R, Weehuizen R, Smit F: Improving the cost-effectiveness of a healthcare system for depressive disorders by implementing telemedicine: a health economic modeling study. Am J Geriatr Psychiatry 2014, 22:253-262.
  • [17]Gerhards SAH, de Graaf LE, Jacobs LE, Severens JL, Huibers MJH, Arntz A, Riper H, Widdershoven G, Metsemakers JFM, Evers SMAA: Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Br J Psychiatry 2010, 196:310-318.
  • [18]Smit F, Willemse G, Meulenbeek P, Koopmanschap M, van Balkom A, Spinhoven P, Cuijpers P: Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trial. Cost Eff Resour Alloc 2009, 7:8.
  • [19]McCrone P: Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 2004, 185:55-62.
  • [20]Riper H, van Ballegooijen W, Kooistra L, de Wit J, Donker T: Preventie & eMental-Health - Prevention & eMental-Health. Vrije Universiteit commissioned by ZonMw, Amsterdam; 2013.
  • [21]Wilhelmsen M, Lillevoll K, Risør MB, Høifødt R, Johansen M-L, Waterloo K, Eisemann M, Kolstrup N: Motivation to persist with internet-based cognitive behavioural treatment using blended care: a qualitative study. BMC Psychiatry 2013, 13:296-304.
  • [22]Månsson KNT, Skagius Ruiz E, Gervind E, Dahlin M, Andersson G: Development and initial evaluation of an Internet-based support system for face-to-face cognitive behavior therapy: a proof of concept study. J Med Internet Res 2013, 15:e280.
  • [23]Thompson SC, Schlehofer MM: The many sides of control motivation. Motives for high, low and illusory control. In Handbook of Motivation Science. Edited by Shah JY, Gardner WL. Guilford Press, New York; 2008:41-56.
  • [24]Van der Zanden R, Galindo-Garre F, Curie K, Kramer J, Cuijpers P: Online cognitive-based intervention for depression: exploring possible circularity in mechanisms of change. Psychol Med 2013, 44:1159-1170.
  • [25]Kessler D, Lewis G, Kaur S, Wiles N, King M, Weich S, Sharp DJ, Araya R, Hollinghurst S, Peters TJ: Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet 2009, 374:628-634.
  • [26]Hickie IB, Davenport TA, Luscombe GM, Moore M, Griffiths KM, Christensen H: Practitioner-supported delivery of internet-based cognitive behaviour therapy: evaluation of the feasibility of conducting a cluster randomised trial. Med J Aust 2010, 192(11 Suppl):S31-S35.
  • [27]Høifødt RS, Lillevoll KR, Griffiths KM, Wilsgaard T, Eisemann M, Waterloo K, Kolstrup N: The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial. J Med Internet Res 2013, 15:e153.
  • [28]Robertson L, Smith M, Castle D, Tannenbaum D: Using the Internet to enhance the treatment of depression. Australas Psychiatry 2006, 14:413-417.
  • [29]Spijker J, Bockting CLH, Meeuwissen JAC, van Vliet IM, Emmelkamp PMG, Hermens MLM, van Balkom A: Multidisciplinaire Richtlijn Depressie (Derde Revisie). Richtlijn voor de Diagnostiek, Behandeling en Begeleiding van Volwassen patiënten met een depressieve stoornis -. Trimbos-instituut, Utrecht; 2013.
  • [30]Butler AC, Chapman JE, Forman EM, Beck AT: The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 2006, 26:17-31.
  • [31]Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, Reed S: Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005, 8:521-533.
  • [32]Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P: Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices-budget impact analysis. Value Health 2007, 10:336-347.
  • [33]Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)–explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013, 16:231-250.
  • [34]Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 2):34-57.
  • [35]Van Vliet IM, De Beurs E: Het Mini Internationaal Neuropsychiatrisch Interview (MINI). Een kort gestructureerd diagnostisch psychiatrisch interview voor DSM-IV en ICD-10-stoornissen - The Mini International Neuropsychiatric Interview (MINI). A short structured diagnostic psychiatric interview for DSM-IV and ICS-10 disorders. Tijdschr Psychiatr 2007, 49:393-397.
  • [36]Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG: CONSORT: explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 2010(63):e1-e37.
  • [37]Moher D, Schulz KF, Altman D: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001, 285:1987-1991.
  • [38]Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 2011, 9:672-677.
  • [39]Bockting CLH, Huibers MJH: Protocollaire behandeling van patiënten met een depressieve stoornis - protocolled treatment of patients with a depressive disorder. In Protocollaire Behandelingen voor Volwassenen met Psychische Klachten I - Protocolled treatments for patients with psychological complaints I. Edited by Keijsers GPJ, Hoogduin CAL. Uitgeverij Boom, Amsterdam; 2011:251-288.
  • [40]Rush AJ, Carmody T, Reimitz P: The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000, 9:45-59.
  • [41]Cusin C, Yang H, Yeung A, Fava M: Rating scales for depression. In Handbook of Clinical Rating Scales and Assessment in Psychiatry and Mental Health. Edited by Baer L, Blais MA. Humana Press, Totowa, NJ; 2010:7-35.
  • [42]Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH: The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-486.
  • [43]Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM: The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004, 34:73-82.
  • [44]Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583.
  • [45]Group EQ: EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
  • [46]Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006, 15:1121-1132.
  • [47]Drummond M, Sculpher M: Common methodological flaws in economic evaluations. Med Care 2005, 43(7 Suppl):5-14.
  • [48]Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart G: Cost Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, Oxford; 2005.
  • [49]Aaronson NK, Muller M, Cohen PDA, Essink-Bot M-L, Fekkes M, Sanderman R, Sprangers MAG, te Velde A, Verrips E: Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068.
  • [50]Bech P, Olsen LR, Kjoller M, Rasmussen NK: Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003, 12:85-91.
  • [51]Ware JEJ, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey: Manual and Interpretation Guide. New England Medical Center, Health Institute, Boston; 1993.
  • [52]Ware JE: SF-36 health survey update. Spine 2000, 25:3130-3139.
  • [53]Brazier J, Roberts J, Deverill M: The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21:271-292.
  • [54]Hakkaart-van Roijen L, van Straten A, Tiemens B, Donker MCH: Manual Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness (TiC-P). Institute of Medical Technology Assessment (iMTA) Erasmus University Rotterdam, Rotterdam; 2002.
  • [55]Tan S, Bouwmans-Frijters CAM, Roijen L: Handleiding voor kostenonderzoek: methoden en referentieprijzen voor economische evaluaties in de gezondheidszorg - Manual for cost research: methods and reference prices for economic evaluations in health care. Tijdschr voor gezondheidswetenschappen 2012, 90:367-372.
  • [56]Pearlin LI, Schooler C: The structure of coping. J Health Soc Behav 1978, 19:2-21.
  • [57]Hatcher RL, Gillaspy JA: Development and validation of a revised short version of the working alliance inventory. Psychother Res 2006, 16:12-25.
  • [58]Stinckens N, Ulburghs A, Claes L: De werkalliantie als sleutelelement in het therapiegebeuren: Meting met behulp van de WAV-12, de Nederlandstalige versie van de Working Alliance Inventory - The working alliance as a key element in therapy: Measurement using the WAV-12, the Dutch shortened version of the Working Alliance Inventory. Tijdschr voor Klin Psychol 2009, 39:44-60.
  • [59]Beck AT, Brown G, Steer RA, Eidelson JI, Riskind JH: Differentiating anxiety and depression: a test of the cognitive content-specificity hypothesis. J Abnorm Psychol 1987, 96:179-183.
  • [60]Steer RA, Beck AT, Clark DA, Beck JS: Psychometric properties of the Cognition Checklist with psychiatric outpatients and university students. Psychol Assess 1994, 6:67-70.
  • [61]Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD: Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann 1979, 2:197-207.
  • [62]De Brey H: A cross-national validation of the Client Satisfaction Questionnaire: the Dutch experience. Eval Program Plann 1983, 6:395-400.
  • [63]Brooke J: SUS: a “quick and dirty” usability scale. In Usability Evaluation in Industry. Edited by Jordan PW, Thomas B, Weerdmeester BA, McClelland IL. Taylor & Francis Ltd, London; 1996:189-194.
  • [64]Bangor A, Kortum PT, Miller JT: An empirical evaluation of the System Usability Scale. Int J Hum Comput Interact 2008, 24:574-594.
  • [65]Bijl RV, van Zessen G, Ravelli A, de Rijk C, Langendoen Y: The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998, 33:581-586.
  • [66]Briggs AH, Claxton K, Sculpher MJ: Decision Modelling for Health Economic Evaluation. Oxford University Press, Oxford; 2006.
  • [67]Bosmans JE, de Bruijne MC, van Hout HPJ, Hermens MLM, Adèr HJ, van Tulder MW: Practical guidelines for economic evaluations alongside equivalence trials. Value Health 2008, 11:251-258.
  • [68]Cohen J: Statistical Power Analysis for the Behavioral Sciences (revised Edition). Lawrence Erlbaum Associates, Inc, Hillsdale, NJ; 1988.
  • [69]Cuijpers P, Huibers M, Ebert DD, Koole SL, Andersson G: How much psychotherapy is needed to treat depression? A metaregression analysis. J Affect Disord 2013, 149:1-13.
  文献评价指标  
  下载次数:17次 浏览次数:10次